J&J: Potential HIV vaccine falls short in mid-stage study

J&J: Potential HIV vaccine falls short in mid-stage study
By

A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.





September 1, 2021 at 02:00AM
via FOX News read more...